STORM in the News
Wuxi AppTec: STORM Therapeutics Pioneering New RNA Pathways to Novel Therapies
CEO Keith Blundy spoke to Wuxi AppTec about STORM Therapeutics trailblazing research into RNA modifying enzymes as part of its “Innovation that Matters” series.
http://wxpress.wuxiapptec.com/storm-therapeutics-pioneering-new-rna-pathways-to-novel-therapies/